MDB Capital Holdings, LLC Class A common (MDBH)

US — Financial Services Sector
Peers:

Automate Your Wheel Strategy on MDBH

With Tiblio's Option Bot, you can configure your own wheel strategy including MDBH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol MDBH
  • Rev/Share 1.3689
  • Book/Share 13.5309
  • PB 0.3306
  • Debt/Equity 0.0
  • CurrentRatio 66.3253
  • ROIC -0.7625

 

  • MktCap 44578827.0
  • FreeCF/Share -1.5944
  • PFCF -5.6476
  • PE 1.8002
  • Debt/Assets 0.0
  • DivYield 0
  • ROE 0.2474

 

  • Rating A
  • Score 4
  • Recommendation Buy
  • P/E Score 4
  • DCF Score 3
  • P/B Score 4
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

New PatentVest Pulse Report Reveals IP Gaps in Billion-Dollar Humanoid Robotics Startups
MDBH
Published: May 14, 2025 by: GlobeNewsWire
Sentiment: Neutral

Despite rising valuations, most humanoid robotics startups remain underprotected—leaving long-term value at risk Despite rising valuations, most humanoid robotics startups remain underprotected—leaving long-term value at risk

Read More
image for news New PatentVest Pulse Report Reveals IP Gaps in Billion-Dollar Humanoid Robotics Startups
Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio
HMTXF, MDBH
Published: April 23, 2025 by: Newsfile Corp
Sentiment: Neutral

Calgary, Alberta--(Newsfile Corp. - April 23, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) a leader in the development of autologous stem cell therapy for the treatment of cardiovascular diseases, announces its partnership with PatentVest. PatentVest, a subsidiary of MDB Capital (NASDAQ: MDBH), is a premier intellectual property strategy and patent prosecution firm specializing in life sciences.

Read More
image for news Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio
MDB Capital Holdings, LLC (MDBH) Q4 2024 Earnings Call Transcript
MDBH
Published: April 03, 2025 by: Seeking Alpha
Sentiment: Neutral

MDB Capital Holdings, LLC (NASDAQ:MDBH ) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET Company Participants Kevin Cotter – Managing Director-Investment Banking Chris Marlett – Chief Executive Officer and Co-Founder Jeremy James – Chief Financial Officer Gary Schuman – Broker Dealer Chief Financial Officer and Head-Compliance Conference Call Participants Kevin Cotter [Call Starts Abruptly] will follow the formal presentation. If you have questions during the presentation, you can type them into the chat to be answered during the question-and-answer period.

Read More
image for news MDB Capital Holdings, LLC (MDBH) Q4 2024 Earnings Call Transcript
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market
MDBH
Published: April 01, 2025 by: GlobeNewsWire
Sentiment: Neutral

Designed for investors, board members, and CEOs, the latest PatentVest Pulse offers a strategic view of who's winning—and why—in the emerging BCI market Designed for investors, board members, and CEOs, the latest PatentVest Pulse offers a strategic view of who's winning—and why—in the emerging BCI market

Read More
image for news New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market
MDB Capital Holdings to Host Fourth Quarter and Full Year 2024 Results Conference Call on Monday March 31, 2025, at 4:30 p.m. Eastern Time
MDBH
Published: March 24, 2025 by: GlobeNewsWire
Sentiment: Neutral

Addison, TX, March 24, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, plans to host a Zoom webinar on Monday March 31, 2025 at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter and full year 2024. A press release detailing these results will be issued prior to the call. Christopher Marlett, CEO and Co-Founder of MDB will lead the call and will be joined by other members of the management team to review recent developments, ongoing initiatives, anticipated milestones, as well as …

Read More
image for news MDB Capital Holdings to Host Fourth Quarter and Full Year 2024 Results Conference Call on Monday March 31, 2025, at 4:30 p.m. Eastern Time
New PatentVest Pulse Report Reveals Transformative Trends in the AI Data Center Patent Race
MDBH
Published: March 05, 2025 by: GlobeNewsWire
Sentiment: Neutral

•China accounts for 77% of all AI data center patent filings globally, with five of the top patent holders hailing from China - underlining its dominant position in next-generation AI infrastructure •China accounts for 77% of all AI data center patent filings globally, with five of the top patent holders hailing from China - underlining its dominant position in next-generation AI infrastructure

Read More
image for news New PatentVest Pulse Report Reveals Transformative Trends in the AI Data Center Patent Race
Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol
MDBH
Published: February 10, 2025 by: GlobeNewsWire
Sentiment: Neutral

Trading Under New Ticker of “EXOZ” Expected to Begin February 12, 2025 Trading Under New Ticker of “EXOZ” Expected to Begin February 12, 2025

Read More
image for news Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol

About MDB Capital Holdings, LLC Class A common (MDBH)

  • IPO Date 2023-09-21
  • Website https://www.mdb.com
  • Industry Financial - Capital Markets
  • CEO Christopher A. Marlett
  • Employees 16

MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business. The company was founded in 1997 and is based in Addison, Texas.